Early Vascular Aging (EVA)
eBook - ePub

Early Vascular Aging (EVA)

New Directions in Cardiovascular Protection

  1. 550 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Early Vascular Aging (EVA)

New Directions in Cardiovascular Protection

About this book

Early Vascular Aging (EVA): New Directions in Cardiovascular Protection, Second Edition continues to be the most comprehensive and authoritative resource on premature alterations in artery structure and function. The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences. This second edition contains completely updated content with expanded coverage of basic and translational research, systematic reviews of the most prominent literature, discussion of applicability of new evidence and more. Written by an international team of clinicians and researchers, this is a valuable resource to basic and translational scientists, clinical researchers and clinicians in the cardiovascular field interested in prevention, diagnosis and treatment of EVA. - Contains all the relevant information available on the main paradigm shifts in vascular aging research, from different fields of knowledge (from basic biology to epidemiology) - Reviews the most prominent evidence produced on early vascular aging (EVA), highlighting recent research advances, clinical applications, and research opportunities - Formulates, in each chapter, a set of research questions that need to be addressed, challenging the vast research community to take on new directions and collaborations

Information

Publisher
Academic Press
Year
2024
Edition
2
eBook ISBN
9780443155130
Topic
Medizin
Subtopic
Geriatrie

Table of contents

  1. Cover
  2. Front Matter
  3. Table of Contents
  4. Copyright
  5. Contributors
  6. In Memoriam
  7. Preface
  8. List of Illustrations
  9. List of Tables
  10. Introduction
  11. Chapter 1 : Historical Aspects and Biology of Aging
  12. Chapter 2 : The 9 Paradigm Shifts in Cardiovascular Aging Research
  13. Chapter 3 : Vascular Aging and Cardiovascular Disease
  14. Introduction
  15. Chapter 4 : Aging Population: Challenges and Opportunities in a Life Course Perspective
  16. Chapter 5 : Population-Based Studies: Milestones on the Epidemiological Timeline
  17. Introduction
  18. Chapter 6 : a. Lessons From the Amsterdam Growth and Health Longitudinal Study
  19. Chapter 7 : b. Cardiovascular Aging: Perspectives From Longitudinal Studies of Aging
  20. Chapter 8 : c. Lessons From the Cardiovascular Risk in Young Finns Study
  21. Chapter 9 : Early Vascular Aging in the Young
  22. Chapter 10 : Ethnicity and Arterial Function
  23. Introduction
  24. Chapter 11 : Cellular and Molecular Determinants of Arterial Aging
  25. Chapter 12 : Platelet/Leukocyte–Vessel Wall Interactions and Early Aging
  26. Chapter 13 : Age-Induced Endothelial Dysfunction and Intima–Media Thickening
  27. Chapter 14 : Diabetes, Prediabetes, Metabolic Syndrome, and Large Artery Vascular Ageing
  28. Chapter 15 : The Cross-Talk Between the Macro- and the Microcirculation
  29. Chapter 16 : Changes in Peripheral Blood Pressure with Normal and Accelerated Aging☆
  30. Chapter 17 : Changes in Arterial Stiffness with Normal and Accelerated Aging
  31. Chapter 18 : Changes in Central Hemodynamics, Wave Reflection, and Heart–Vessel Coupling with Normal and Accelerated Aging
  32. Chapter 19 : Arterial Stiffness and Blood Pressure Variability
  33. Chapter 20 : Chronic Inflammation in Atherosclerosis and Arteriosclerosis
  34. Chapter 21 : Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS)
  35. Chapter 22 : Microbiota, Diet, Oral Health, and Vascular Aging
  36. Introduction
  37. Chapter 23 : Traditional Versus New Models of Risk Prediction
  38. Chapter 24 : Estimated Arterial Stiffness
  39. Chapter 25 : Vascular Aging Biomarkers: Methodological Measurement Consensus and Reference Values
  40. Chapter 26 : Imaging Biomarkers: Carotid Intima-Media Thickness and Aortic Stiffness as Predictors of Cardiovascular Disease
  41. Chapter 27 : Imaging Biomarkers: Flow-Mediated Dilation as Predictor in Cardiovascular Disease
  42. Chapter 28 : Genetic Markers in Predicting Three Common Vascular Diseases
  43. Chapter 29 : Phenotypes of Vascular Aging
  44. Introduction
  45. Chapter 30 : Early and Late Stages of Chronic Kidney Disease in Relation to Arterial Changes
  46. Chapter 31 : Arterial Aging, Blood Pressure, and Brain Damage
  47. Chapter 32 : Clinical Implications of Ventricular-Arterial Coupling and the Role of Therapeutic Interventions
  48. Chapter 33 : Systemic Ventricular–Arterial Coupling and Heart Disease
  49. Introduction
  50. Chapter 34 : Vascular Aging and Clinical Trials
  51. Introduction
  52. Chapter 35 : a. Part I: Treatment of Abnormalities in Lipid Metabolism and EVA
  53. Chapter 36 : b. Part II: Early Vascular Aging and Obesity Treatment
  54. Chapter 37 : c. Part III: Treatment with Antidiabetes Drugs—Effects on Blood Pressure and Central Hemodynamics
  55. Chapter 38 : d. Part IV: Arterial Stiffness as Treatment Target: The SPARTE Study
  56. Chapter 39 : Lifestyle Intervention: What Works?
  57. Chapter 40 : Targeting Blood Pressure Lowering and the Sympathetic Nervous System
  58. Chapter 41 : Targeting Central Blood Pressure Through the Macro- and Microcirculation Cross-Talk
  59. Introduction
  60. Chapter 42 : a. Cardiovascular Prevention Strategies in a Life Course Perspective
  61. Chapter 43 : b. Cardiovascular Prevention Strategies in Patients With Comorbidities (Metabolic, Chronic Inflammation, Immunomodulation, Cancer, and Treatment-Induced Arterial Changes)
  62. Chapter 44 : c. Cardiovascular Risk Prediction
  63. Chapter 45 : d. Target Organ Damage
  64. Chapter 46 : e. Therapeutic Implications of Early Vascular Aging
  65. Chapter 47 : New Drugs Under Development for Cardiovascular Prevention
  66. Chapter 48 : Specific Pathways to Prevent Early Vascular Aging
  67. Chapter 49 : Immunization, Vaccines, and Immunomodulation
  68. Introduction
  69. Introduction
  70. Chapter 50 : a. European Research Centres
  71. Chapter 51 : b. Asia/Australia Research Centers
  72. Chapter 52 : c. North American Research Centers
  73. Chapter 53 : d. Latin American Research Centers
  74. Chapter 54 : e. Network for Research in Vascular Aging
  75. Index
  76. A

Trusted by 375,005 students

Access to over 1.5 million titles for a fair monthly price.

Study more efficiently using our study tools.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn how to download books offline
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.5M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1.5 million books across 990+ topics, we’ve got you covered! Learn about our mission
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more about Read Aloud
Yes! You can use the Perlego app on both iOS and Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Yes, you can access Early Vascular Aging (EVA) by Pedro Guimarães Cunha, Pierre Boutouyrie, Michael Hecht Olsen, Peter M Nilsson, Stephane Laurent, Pedro Guimarães Cunha,Pierre Boutouyrie,Michael Hecht Olsen,Peter M Nilsson,Stephane Laurent in PDF and/or ePUB format, as well as other popular books in Medizin & Geriatrie. We have over 1.5 million books available in our catalogue for you to explore.